Acute lymphocytic leukemia is also referred to as acute lymphoblastic leukemia (ALL). “Acute” means that leukemia can develop rapidly, and is likely to be lethal within a couple of months if not treated. “Lymphocytic” means that it produces a type of white blood cell from early (immature) types of lymphocytes.
In the bone marrow, ALL begins (the soft inner part of certain bones, where new blood cells are made). Very commonly, blood is infiltrated very rapidly by leukemia cells. They can also spread to other parts of the body often, including the lymph nodes, liver, spleen, brain and spinal cord, central nervous system, and testicles (in males). In these organs, some cancers can also begin and then spread to the bone marrow, but these cancers are not leukemia.
A type of blood and bone marrow cancer, the spongy tissue inside the bones where blood cells are formed, is acute lymphocytic leukemia (ALL).
In acute lymphocytic leukemia, the term “acute” comes from the fact that the disease progresses quickly and produces immature blood cells instead of mature ones. In acute lymphocytic leukemia, the term “lymphocytic” refers to the white blood cells called lymphocytes affected by Everything. Acute lymphocytic leukemia is often referred to as acute lymphoblastic leukemia.
The most common form of cancer in children is acute lymphocytic leukemia, and therapies result in a strong chance of a cure. There can also be acute lymphocytic leukemia in adults, but the likelihood of a cure is significantly diminished.
Causes and Risk Factors for Acute Lymphoblastic Leukemia
Doctors are unsure of what triggers the bulk of ALL incidents. But studies have found that certain items could increase your risk, including:
Symptoms of acute lymphocytic leukemia (ALL)
Signs and symptoms of acute lymphocytic leukemia may include:
Causes of acute lymphocytic leukemia (ALL)
When a bone marrow cell produces errors in its DNA, acute lymphocytic leukemia occurs. When a healthy cell usually stops dividing and ultimately dies, the errors tell the cell to continue developing and dividing. The development of blood cells becomes irregular when this occurs. The bone marrow generates immature cells that turn into lymphoblasts called leukemic white blood cells. These dysfunctional cells cannot function properly, and healthy cells can be built up and crowded out.
What triggers the DNA mutations which can lead to acute lymphocytic leukemia is not clear. Yet most cases of acute lymphocytic leukemia are not hereditary, doctors have found.
Risk factors for acute lymphocytic leukemia (ALL)
The following are factors that can raise the risk of acute lymphocytic leukemia:
Treatment for past cancer : There could be an elevated risk of developing acute lymphocytic leukemia in children and adults who have had some forms of chemotherapy and radiation therapy for other kinds of cancer.
Radiation sensitivity : There is an elevated risk of developing acute lymphocytic leukemia in individuals who are exposed to extremely high levels of radiation, such as survivors of a nuclear reactor accident.
Having inherited disorders: An elevated risk of acute lymphocytic leukemia is associated with some genetic conditions, such as Down syndrome.
Getting an all-ALL brother or sister: People with acute lymphocytic leukemia who have a sibling, even a twin, have an increased chance of developing Both.
Acute Lymphoblastic Leukemia Diagnosis
Your doctor will ask about your symptoms and medical history. They’ll do a physical exam to look for swollen lymph nodes, bleeding and bruising, or signs of infection.
If your doctor suspects leukemia, they may do tests, including:
Your doctor can also monitor for changes in your chromosomes in your blood or bone marrow, or check for cancer cell markers. The findings will teach them all about the type of leukemia that you have and help prepare the care for them.
Acute Lymphoblastic Leukemia Treatment
Treatment happens in two parts: induction therapy, to put you in remission, and post-remission therapy.
You may have more than one type of treatment. These include:
About 80% to 90% of adults reach remission after treatment. For about 30% to 40%, the cancer doesn’t return. But many relapse, meaning the disease returns.
You’ll need post-remission therapy to keep the cancer from coming back. This involves cycles of treatment over 2 to 3 years. It aims to rid your body of leukemia cells.
The FDA has also approved a form of treatment called CAR T-cell therapy. It uses some of your own immune cells, called T cells, to treat your cancer. Doctors take the cells out of your blood and add genes to them. The new T cells are better able to find and kill cancer cells. CAR T Cell therapy in China has gained a lot of attention because of the number of clinical trials running across the big hospitals.
Privacy Overview